8-K/A: T3 Defense Corrects Warrant Exercise Price in Private Placement

T3 Defense Inc. filed an amended 8-K to correct a typographical error regarding the exercise price of common stock purchase warrants issued in a recent $20 million private placement.

Summary

• T3 Defense Inc. (the Company) filed a Current Report on Form 8-K/A to amend its original Form 8-K filed on February 25, 2026.
• The amendment corrects a typographical error in the original filing concerning the exercise price of Common Warrants.
• The original Form 8-K disclosed a private placement consisting of 400 units for an aggregate purchase price of $20,000,000, with a per unit price of $50,000.
• Each unit in the private placement consists of one share of Series B Convertible Preferred Stock, par value $0.0001 per share, and one and a half common stock purchase warrants.
• The correct initial exercise price for each Common Warrant is $2.13 per share, subject to adjustment for stock splits, distributions, and the like.
• The original Form 8-K inadvertently disclosed an incorrect exercise price for these warrants.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development. While an error requiring an amendment is not ideal, the prompt correction of a material term demonstrates transparency and ensures accurate disclosure for investors, which is a positive for corporate governance.

Positives

• The company successfully secured $20,000,000 through a private placement of 400 units, indicating investor confidence and providing capital.
• The prompt correction of a material typographical error demonstrates transparency and commitment to accurate disclosure.

Negatives

• An initial typographical error in a material definitive agreement required an amendment, which could momentarily create confusion for investors.

Risks

• The issuance of Series B Convertible Preferred Stock and Common Warrants could lead to future dilution for existing common stockholders upon conversion or exercise.
• The value of the warrants is subject to the future performance of the common stock and market conditions.

Future Outlook

The private placement, including the issuance of common stock purchase warrants, indicates a future potential for additional common stock issuance upon warrant exercise, subject to the corrected exercise price of $2.13 per share and other adjustments.

Management Comments

• "Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized." (Signed by Menachem Shalom, Chief Executive Officer)

Industry Context

StockSavvy.ai notes that private placements are a common method for companies, particularly those seeking growth capital, to raise funds quickly from institutional or accredited investors. The correction of a material term like a warrant exercise price, while an administrative error, underscores the importance of precision in SEC filings, as such terms directly impact investor returns and potential dilution.

Stakeholder Impact

• Shareholders: The clarification of the warrant exercise price provides accurate information for assessing potential future dilution and the value of the warrants. The original private placement itself introduces potential future dilution from preferred stock conversion and warrant exercise.
• Investors in the Private Placement: The correction ensures they have accurate terms for their warrants, which is crucial for their investment calculations.

Next Steps

• Common Warrants will be exercisable for one share of Common Stock at an initial exercise price of $2.13 per share, subject to adjustment.

Key Dates

Keywords

T3 Defense, DFNS, 8-K/A, SEC Filing, Private Placement, Warrants, Preferred Stock, Capital Raise, Typographical Error, Securities Purchase Agreement